Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stericycle settles with Saddle Point for two board seats: sources

Published 03/27/2020, 07:54 AM
Updated 03/27/2020, 07:55 AM
© Reuters.

By Svea Herbst-Bayliss

BOSTON (Reuters) - Medical waste company Stericycle (O:SRCL) and investment firm Saddle Point Management reached a settlement that hands the firm, founded by a former Pershing Square (NYSE:SQ) Capital Management partner, two board seats, said two sources familiar the matter.

Stericycle will expand its 10-member board to 12 people and offer seats to James Martell, a former XPO Logistics (N:XPO) director, and James Welch, a former chief executive at YRC Worldwide (O:YRCW).

The men were nominated by Saddle Point and bring expertise in trucking and logistics at a time some Stericycle investors have asked the $3.8 billion company to cut costs, pay down debt and sell non-core assets. Saddle Point did not press for any changes publicly.

Stericycle and Saddle Point were not immediately available for comment.

New York-based Saddle Point was founded two years ago by Roy Katzovicz, who had been chief legal officer and an investment team member at William Ackman's activist hedge fund Pershing Square Capital Management.

Until now, Katzovicz has largely stayed out of the public eye. He has made a few behind the scenes investments in companies including Sprout Pharmaceuticals and BacterioScan Inc, a point-of-care and rapid diagnostic device development and manufacturing company.

Saddle Point requested and received confidential treatment from the Securities and Exchange Commission to build the stake.

Stericycle is the dominant U.S. medical waste company that disposes syringes, used gloves, and bloody bandages among other things for hospitals and doctors' and dentists' offices. It is also active in document and data shredding.

After having gone public in 1996, the company grew by buying up competitors. Its stock price climbed from $2.31 at the IPO to $141 in 2015. But rapid growth came at a price and the company's international expansion was more uneven. Its stock price closed at $43.15 on Thursday.

In 2017 the company paid $295 million to settle a class-action lawsuit which charged the company engaged in a price-increasing scheme that automatically increased clients' bills.

The company last year promoted Cindy Miller to chief executive after she joined as president and chief operating officer in 2018 after nearly 30 years at UPS.

Several prominent activist investors including Carl Icahn, Elliott Management and Starboard Value have made demands more publicly and recently agreed to settle for board seats at companies ranging from Occidental Petroleum (N:OXY)to Twitter (N:TWTR) as the spread of the coronavirus accelerated some talks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.